1	Distinct	distinct	_	_	_	_	_	_	_
2	DNase-I	DNase-I	_	_	_	_	_	_	_
3	hypersensitive	hypersensitive	_	_	_	_	_	_	_
4	sites	site	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	associated	associate	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	TAL-1	tal-1	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	erythroid	erythroid	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	T-cell	t-cell	_	_	_	_	_	_	_
14	lines	line	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	tal-1	tal-1	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	frequently	frequently	_	_	_	_	_	_	_
6	activated	activate	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	T-cell	t-cell	_	_	_	_	_	_	_
10	acute	acute	_	_	_	_	_	_	_
11	lymphoblastic	lymphoblastic	_	_	_	_	_	_	_
12	leukemia	leukemia	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	T-ALL	T-ALL	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	expressed	express	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	erythroid	erythroid	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	megakaryocytic	megakaryocytic	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	mast	mast	_	_	_	_	_	_	_
27	cell	cell	_	_	_	_	_	_	_
28	lineages	lineage	_	_	_	_	_	_	_
29	during	during	_	_	_	_	_	_	_
30	normal	normal	_	_	_	_	_	_	_
31	hematopoiesis	hematopoiesis	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	gain	gain	_	_	_	_	_	_	_
3	further	further	_	_	_	_	_	_	_
4	insight	insight	_	_	_	_	_	_	_
5	into	into	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	molecular	molecular	_	_	_	_	_	_	_
8	mechanisms	mechanism	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	control	control	_	_	_	_	_	_	_
11	tal-1	tal-1	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	we	we	_	_	_	_	_	_	_
15	investigated	investigate	_	_	_	_	_	_	_
16	tal-1	tal-1	_	_	_	_	_	_	_
17	chromatin	chromatin	_	_	_	_	_	_	_
18	structure	structure	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	erythroid/megakaryocytic	erythroid/megakaryocytic	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	T-cell	t-cell	_	_	_	_	_	_	_
26	lines	line	_	_	_	_	_	_	_
27	either	either	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	or	or	_	_	_	_	_	_	_
30	without	without	_	_	_	_	_	_	_
31	tal-1	tal-1	_	_	_	_	_	_	_
32	rearrangements	rearrangement	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Tal-1	tal-1	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	monoallelic	monoallelic	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	Jurkat	Jurkat	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	T-cell	t-cell	_	_	_	_	_	_	_
13	line	line	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	expresses	express	_	_	_	_	_	_	_
16	tal-1	tal-1	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	absence	absence	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	apparent	apparent	_	_	_	_	_	_	_
22	genomic	genomic	_	_	_	_	_	_	_
23	alteration	alteration	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	locus	locus	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Methylation	methylation	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	indicated	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	tal-15	tal-15	_	_	_	_	_	_	_
7	â€™	'	_	_	_	_	_	_	_
8	GC-rich	gc-rich	_	_	_	_	_	_	_
9	region	region	_	_	_	_	_	_	_
10	behaves	behave	_	_	_	_	_	_	_
11	like	like	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	CpG	CpG	_	_	_	_	_	_	_
14	island	island	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	hypomethylated	hypomethylate	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	normal	normal	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	methylated	methylate	_	_	_	_	_	_	_
23	de	de	_	_	_	_	_	_	_
24	novo	novo	_	_	_	_	_	_	_
25	on	on	_	_	_	_	_	_	_
26	transcriptionally	transcriptionally	_	_	_	_	_	_	_
27	inactive	inactive	_	_	_	_	_	_	_
28	alleles	allele	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	established	established	_	_	_	_	_	_	_
31	cell	cell	_	_	_	_	_	_	_
32	lines	line	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Five	five	_	_	_	_	_	_	_
2	major	major	_	_	_	_	_	_	_
3	DNase-I	DNase-I	_	_	_	_	_	_	_
4	hypersensitive	hypersensitive	_	_	_	_	_	_	_
5	sites	site	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	HS	HS	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	mapped	map	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	tal-1	tal-1	_	_	_	_	_	_	_
14	locus	locus	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	HS	HS	_	_	_	_	_	_	_
2	I	i	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	IV	iv	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	V	V	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	exclusively	exclusively	_	_	_	_	_	_	_
10	observed	observe	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	erythroid/megakaryocytic	erythroid/megakaryocytic	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	lines	line	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	express	express	_	_	_	_	_	_	_
18	tal-1	tal-1	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	promoters	promoter	_	_	_	_	_	_	_
22	1a	1a	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	1b.	1b.	_	_	_	_	_	_	_
25	HS	HS	_	_	_	_	_	_	_
26	II	ii	_	_	_	_	_	_	_
27	was	be	_	_	_	_	_	_	_
28	weak	weak	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	hematopoietic	hematopoietic	_	_	_	_	_	_	_
31	cell	cell	_	_	_	_	_	_	_
32	lines	line	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	absent	absent	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	Hela	Hela	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	greatly	greatly	_	_	_	_	_	_	_
40	enhanced	enhance	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	Jurkat	Jurkat	_	_	_	_	_	_	_
43	,	,	_	_	_	_	_	_	_
44	suggesting	suggest	_	_	_	_	_	_	_
45	that	that	_	_	_	_	_	_	_
46	this	this	_	_	_	_	_	_	_
47	region	region	_	_	_	_	_	_	_
48	might	might	_	_	_	_	_	_	_
49	be	be	_	_	_	_	_	_	_
50	implicated	implicate	_	_	_	_	_	_	_
51	in	in	_	_	_	_	_	_	_
52	the	the	_	_	_	_	_	_	_
53	cis-activation	cis-activation	_	_	_	_	_	_	_
54	of	of	_	_	_	_	_	_	_
55	tal-1	tal-1	_	_	_	_	_	_	_
56	promoter	promoter	_	_	_	_	_	_	_
57	1b	1b	_	_	_	_	_	_	_
58	in	in	_	_	_	_	_	_	_
59	this	this	_	_	_	_	_	_	_
60	cell	cell	_	_	_	_	_	_	_
61	line	line	_	_	_	_	_	_	_
62	.	.	_	_	_	_	_	_	_

1	HS	HS	_	_	_	_	_	_	_
2	III	iii	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	weak	weak	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	HEL	HEL	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	Jurkat	Jurkat	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	greatly	greatly	_	_	_	_	_	_	_
12	enhanced	enhance	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	DU528	du528	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	T-cell	t-cell	_	_	_	_	_	_	_
18	line	line	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	bears	bear	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	t	t	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	1;14	1;14	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	initiates	initiate	_	_	_	_	_	_	_
28	tal-1	tal-1	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	within	within	_	_	_	_	_	_	_
31	exon	exon	_	_	_	_	_	_	_
32	4	4	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	distinct	distinct	_	_	_	_	_	_	_
6	regulatory	regulatory	_	_	_	_	_	_	_
7	elements	element	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	use	use	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	different	different	_	_	_	_	_	_	_
16	tal-1	tal-1	_	_	_	_	_	_	_
17	promoters	promoter	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

